Burzynski Research Institute, Inc. engages in research, production, marketing, promotion and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids under the trade name Antineoplastons. The company was founded by Stanislaw R. Burzynski in 1984 and is headquartered in Houston, TX.